Literature DB >> 4788032

The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice.

G B Chesher, C J Dahl, M Everingham, D M Jackson, H Marchant-Williams, G A Starmer.   

Abstract

1. After oral administration to mice, pethidine, Delta(8)-tetrahydrocannabinol (THC), Delta(9)-THC, a cannabis extract and cannabinol had a dose-dependent antinociceptive effect when measured by the hot-plate method. Cannabidiol was inactive at 30 mg/kg. Delta(8)-THC, Delta(9)-THC and pethidine did not differ significantly in potency, but Delta(9)-THC was 6.5 times more active than cannabinol.2. After oral administration, three different cannabis extracts, Delta(8)-THC, Delta(9)-THC and morphine produced dose-dependent depressions of the passage of a charcoal meal in mice. Delta(8)-THC and Delta(9)-THC were equipotent and were about five times less potent than morphine. Cannabidiol was inactive up to 30 mg/kg. The effect of the three cannabis extracts on intestinal motility could be accounted for by their Delta(9)-THC content.3. The antinociceptive effect of pethidine and the effect of morphine on intestinal motility were antagonized by nalorphine whilst the effects of the cannabis extracts and the pure cannabinoids were not.4. From these results it is concluded that although cannabis and the narcotics share several common pharmacological properties, the mode of action of each is pharmacologically distinct.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4788032      PMCID: PMC1776598          DOI: 10.1111/j.1476-5381.1973.tb08534.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  8 in total

1.  THE USE OF CHANGES IN CAPILLARY PERMEABILITY IN MICE TO DISTINGUISH BETWEEN NARCOTIC AND NONNARCOTIC ALALGESICS.

Authors:  B A WHITTLE
Journal:  Br J Pharmacol Chemother       Date:  1964-04

2.  Marihuana: importance of the route of administration.

Authors:  B T Ho; G E Fritchie; L F Englert; W M McIsaac; J E Idänpään-Heikkilä
Journal:  J Pharm Pharmacol       Date:  1971-04       Impact factor: 3.765

3.  Pharmacological effects of two active constituents of marihuana.

Authors:  H I Bicher; R Mechoulam
Journal:  Arch Int Pharmacodyn Ther       Date:  1968-03

4.  Some pharmacological and toxicological effects of 1-trans- 8 and 1-trans- 9 -tetrahydrocannabinol in laboratory rodents.

Authors:  W L Dewey; L S Harris; J S Kennedy
Journal:  Arch Int Pharmacodyn Ther       Date:  1972-03

5.  Analgesic activity of 9 -tetrahydrocannabinol in the rat and mouse.

Authors:  D M Buxbaum
Journal:  Psychopharmacologia       Date:  1972

6.  Effect of 9 -THC on the open-field activity of the rat.

Authors:  W G Drew; L L Miller; A Wikler
Journal:  Psychopharmacologia       Date:  1972

7.  Influence of (-) 9 -trans-tetrahydrocannabinol and mescaline on the behavior of rats submitted to food competition situations.

Authors:  J Masur; R M Martz; D Bieniek; F Korte
Journal:  Psychopharmacologia       Date:  1971

8.  Effect of cannabis and certain of its constituents on pentobarbitone sleeping time and phenazone metabolism.

Authors:  W D Paton; R G Pertwee
Journal:  Br J Pharmacol       Date:  1972-02       Impact factor: 8.739

  8 in total
  23 in total

Review 1.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  Investigation on the relationship between cannabinoid CB1 and opioid receptors in gastrointestinal motility in mice.

Authors:  Mauro A M Carai; Giancarlo Colombo; Gian Luigi Gessa; Ratnakumar Yalamanchili; Balapal S Basavarajappa; Balapal S Basavarajppa; Basalingappa L Hungund
Journal:  Br J Pharmacol       Date:  2006-07-17       Impact factor: 8.739

3.  Brain Mapping-Based Model of Δ(9)-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix.

Authors:  Carmen Walter; Bruno G Oertel; Lisa Felden; Christian A Kell; Ulrike Nöth; Johannes Vermehren; Jochen Kaiser; Ralf Deichmann; Jörn Lötsch
Journal:  Neuropsychopharmacology       Date:  2015-10-30       Impact factor: 7.853

4.  Possible mediation of catecholaminergic pathways in the antinociceptive effect of an extract of Cannabis sativa L.

Authors:  S Ferri; E Cavicchini; P Romualdi; E Speroni; G Murari
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse.

Authors:  A S Bloom; W L Dewey
Journal:  Psychopharmacology (Berl)       Date:  1978-05-31       Impact factor: 4.530

6.  Effect of cannabinoids on the abdominal constriction response in mice: within cannabinoid interactions.

Authors:  P J Welburn; G A Starmer; G B Chesher; D M Jackson
Journal:  Psychopharmacologia       Date:  1976

7.  Central and peripheral cannabinoid modulation of gastrointestinal transit in physiological states or during the diarrhoea induced by croton oil.

Authors:  A A Izzo; L Pinto; F Borrelli; R Capasso; N Mascolo; F Capasso
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

8.  Analgesic and antiinflammatory activity of constituents of Cannabis sativa L.

Authors:  E A Formukong; A T Evans; F J Evans
Journal:  Inflammation       Date:  1988-08       Impact factor: 4.092

9.  Interactions among the cannabinoids in the antagonism of the abdominal constriction response in the mouse.

Authors:  J Sanders; D M Jackson; G A Starmer
Journal:  Psychopharmacology (Berl)       Date:  1979-03-28       Impact factor: 4.530

10.  The interaction between prostaglandin E1 and delta 9-tetrahydrocannabinol on intestinal motility and on the abdominal constriction response in the mouse.

Authors:  D M Jackson; R Malor; G B Chesher; G A Starmer; P J Welburn; R Bailey
Journal:  Psychopharmacologia       Date:  1976-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.